ANRO
Alto NeuroscienceBNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
ANRO vs peer average
61/100
ANRO vs. peer average (B vs. C)
Grade spread
A 4 · B 1 · C 1 · D 2 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
CRVS is the first available peer comparator.
Another loose sub-$1 billion clinical-stage biotech comparator where valuation is heavily driven by cash runway and upcoming trial outcomes rather than commercial revenue.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ANRO
Alto Neuroscience
CRVS
Corvus
Grade
B
D
Momentum
61
10
Value
41
41
Sentiment
83
83
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs CRVS
ANRO / CRVS
Grade Position
In line
ANRO vs. peer average (B vs. C)
61/100
Momentum
61
ANROValue
41
ANROSentiment
83
CRVSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ANRO
CRVS is the first peer returned for this comparison set.